The Rise and Fall of Safer Supply Programs in Canada

This Viewpoint discusses the implementation and subsequent deimplementation of safer supply programs in Canada, which provided access to pharmaceutical-grade medications for individuals who use unregulated substances, particularly opioids.

Corresponding Author: Mohammad Karamouzian, PhD, Centre on Drug Policy Evaluation, Li Ka Shing Knowledge Institute, St Michael’s Hospital, 30 Bond St, Toronto, ON M5B 1W8, Canada (mohammad.karamouzian@unityhealth.to).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.